How has the US market performed recently?

The US market has risen 1.3% over the past seven days and 28% over the past year, with earnings forecast to grow 17% annually.

Does the Simply Wall St analysis recommend buying AbbVie stock?

No, the analysis is not a buy or sell recommendation; it merely indicates that the stock may be undervalued according to their assumptions.

AbbVie (ABBV) Stock Trading 14.6% Below Intrinsic Value

According to Simply Wall St analysis, AbbVie (ABBV) is trading at least 14.6% below its intrinsic value. This comes as the US market has risen 1.3% over the past week and 28% over the past year, with earnings forecast to grow 17% annually.

By: Wrqti Editorial

May 28, 2026

2 min read

Source: Simply Wall St.

Key Numbers

market rise 7d

1.3%

market rise 1y

28%

earnings growth forecast

17%

discount to intrinsic

14.6%

A recent analysis by Simply Wall St indicates that AbbVie Inc. (ABBV) is currently trading at least 14.6% below its estimated intrinsic value. This assessment comes amid a strong US market, which has gained 1.3% over the past seven days and 28% over the past year, with corporate earnings expected to grow 17% annually.

Details

The analysis focused on identifying stocks that may be undervalued in the current bullish market. Using a discounted cash flow methodology, Simply Wall St estimated AbbVie's intrinsic value and compared it to the current market price. The result shows a discount of over 14.6%.

Context

This valuation occurs in a generally positive market environment, with the US market index rising 1.3% over the past week, reflecting investor confidence. However, identifying undervalued stocks requires careful analysis of each company's fundamentals.

What This Means for Investors

This analysis is not a buy or sell recommendation but rather an indication that AbbVie may be undervalued according to Simply Wall St's assumptions. Investors should conduct their own research and consider other factors such as regulatory risks and competition in the healthcare sector before making any investment decisions.

Frequently Asked Questions

According to Simply Wall St analysis, AbbVie is trading at a discount of at least 14.6% to its estimated intrinsic value.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.